Free Account Opening + AMC Free Demat
Loading...

Credent Global Finance Rights Issue 2023 vs Eiko Lifesciences Rights Issue 2023

Comparision between Credent Global Finance Rights Issue 2023 and Eiko Lifesciences Rights Issue 2023.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Credent Global Finance Rights Issue 2023 and Eiko Lifesciences Rights Issue 2023. Credent Global Finance Rights Issue 2023 is listed on BSE while Eiko Lifesciences Rights Issue 2023 is listed on BSE.

  Credent Global Finance Limited Eiko Lifesciences Limited
Logo Credent Global Finance Rights Issue 2023 Logo Eiko Lifesciences Rights Issue 2023 Logo
Listing At BSE BSE
Terms of Payment

On Application, Investors will have to pay Rs. 140 per Rights Equity Share, which constitutes 100% of the Issue price.

The amount of Rs. 13.50 per Rights Equity Share (including premium of Rs. 10.50) is to be paid on the Application. Balance to be paid in not more than two calls as determined by the Board.

Entitlement 1 Rights Equity Share(s) for every 2 fully paid-up Equity Shares held on Record Date 2 Rights Equity Share(s) for every 3 fully paid-up Equity Shares held on Record Date
Application Form Application Form Application Form
Letter of Offer Letter of Offer Letter of Offer
Registrar Beetal Financial & Computer Services (P) Limited Bigshare Services Pvt Ltd
Lead Managers Pnb Investment Services Ltd

Rights Issue Size and Price

The issue size of Credent Global Finance Rights Issue 2023 rights issue is ₹48.56 Crores, whereas Eiko Lifesciences Rights Issue 2023 rights issue size is ₹24.95 Crores.

  Credent Global Finance Limited Eiko Lifesciences Limited
Issue Size 34,68,750 shares 55,44,178 shares
Issue Size (Amount) ₹48.56 Crores ₹24.95 Crores
Issue Price ₹140 per share ₹45 per share
Face Value ₹10 per share ₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Credent Global Finance Rights Issue 2023 is Jul 17, 2023 while record date of Eiko Lifesciences Rights Issue 2023 is Jul 07, 2023.

  Credent Global Finance Limited Eiko Lifesciences Limited
Record Date Jul 17, 2023 Jul 07, 2023
Credit of Rights Entitlements Jul 24, 2023 Jul 12, 2023
Bid/Offer Opens On Jul 25, 2023 Jul 17, 2023
Renunciation of Rights Entitlements Aug 10, 2023 Jul 20, 2023
Bid/Offer Closes On Aug 14, 2023 Jul 26, 2023
Deemed Date of Allotment Aug 14, 2023 Aug 03, 2023
Credit Date Aug 17, 2023 Aug 04, 2023
Listing Date Aug 21, 2023 Aug 10, 2023

Financials details

Comparison of Credent Global Finance Rights Issue 2023 and Eiko Lifesciences Rights Issue 2023 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

  Credent Global Finance Limited Eiko Lifesciences Limited
Financial
Credent Global Finance Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After Tax
31-Mar-227.921.901.07
31-Mar-2375.8019.576.74
Amount in ₹ Crore
Eiko Lifesciences Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After Tax
31-Mar-2116.6112.450.61
31-Mar-2234.8926.090.71
Amount in ₹ Crore

Comments

Add a public comment...